Literature DB >> 31414567

Gender differences in early onset of chronic physical multimorbidities in schizophrenia spectrum disorder: Do women suffer more?

Ivona Šimunović Filipčić1, Ena Ivezić2, Nenad Jakšić1, Nina Mayer2, Majda Grah2, Martina Rojnić Kuzman1,3, Zarko Bajić2, Vesna Svab4, Miroslav Herceg3,5, Igor Filipčić2,3,6.   

Abstract

AIM: The association between various physical illnesses and schizophrenia spectrum disorder (SSD) is well-established. However, the role of gender remains unclear. The present study explored the gender-based differences in the prevalence and early onset of chronic physical multimorbidities (CPM) in patients with SSD and the general population (GEP).
METHODS: We recruited 329 SSD patients and 837 GEP controls in this nested cross-sectional study. The primary outcome was the prevalence of the chronic physical multimorbidities, especially in the youngest age group (<35 years).
RESULTS: Women with SSD had more than double the odds for having CPM than men (OR = 2.47; 95% CI 1.35-4.50), while the gender-related burden of chronic diseases in controls was nearly the same (OR = 0.89; 95% CI 0.65-1.22). Furthermore, the prevalence of chronic disease in younger women patients was significantly higher than in controls (P = .002), while younger men did not seem to experience this increased comorbidity burden.
CONCLUSIONS: This study suggests that women with SSD are at increased physical comorbidity risk compared to men, particularly early in the course of psychiatric illness. Tailored and individualized treatment plans must consider this, aiming to deliver holistic care and effective treatment outcomes.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  gender; medical illness; multimorbidity; schizophrenia spectrum; severe mental illness

Year:  2019        PMID: 31414567     DOI: 10.1111/eip.12867

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  5 in total

1.  Predictors of Frequent Emergency Department Use and Hospitalization among Patients with Substance-Related Disorders Recruited in Addiction Treatment Centers.

Authors:  Marie-Josée Fleury; Zhirong Cao; Guy Grenier; Christophe Huỳnh
Journal:  Int J Environ Res Public Health       Date:  2022-05-28       Impact factor: 4.614

Review 2.  Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review.

Authors:  Giulia Maria Giordano; Paola Bucci; Armida Mucci; Pasquale Pezzella; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2021-12-22       Impact factor: 4.157

3.  Gender Differences in Psychiatric Symptoms and the Social Functioning of 610 Patients with Schizophrenia in Urban China: A 10-Year Follow-Up Study.

Authors:  Jintao Zhao; Jian Diao; Xiaoyue Li; Yating Yang; Yitan Yao; Shengya Shi; Xiaoping Yuan; Huanzhong Liu; Kai Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-27       Impact factor: 2.989

Review 4.  Psychosis in Women: Time for Personalized Treatment.

Authors:  Marianna Mazza; Emanuele Caroppo; Domenico De Berardis; Giuseppe Marano; Carla Avallone; Georgios D Kotzalidis; Delfina Janiri; Lorenzo Moccia; Alessio Simonetti; Eliana Conte; Giovanni Martinotti; Luigi Janiri; Gabriele Sani
Journal:  J Pers Med       Date:  2021-12-02

5.  The prevalence of physical multimorbidity among people with non-affective psychotic disorders 10 years after first diagnosis: a matched retrospective cohort study.

Authors:  Myanca Rodrigues; Saverio Stranges; Bridget L Ryan; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-08-06       Impact factor: 4.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.